Literature DB >> 6213948

Warfarin-induced vasculitis: a dose-related phenomenon in susceptible individuals?

A J Howitt, A J Williams, C Skinner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213948      PMCID: PMC2426397          DOI: 10.1136/pgmj.58.678.233

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  PETECHIAE, ECCHYMOSES, AND NECROSIS OF SKIN INDUCED BY COUMARIN CONGENERS: RARE, OCCASIONALLY LETHAL COMPLICATION OF ANTICOAGULANT THERAPY.

Authors:  R M NALBANDIAN; I J MADER; J L BARRETT; J F PEARCE; E C RUPP
Journal:  JAMA       Date:  1965-05-17       Impact factor: 56.272

2.  Skin petechiae and ecchymoses (vasculitis) due to anticoagulant therapy.

Authors:  M Stavorovsky; D Lichtenstein; F Nissim
Journal:  Dermatologica       Date:  1979

3.  Necrosis of the breast: a rare complication of anticoagulant therapy.

Authors:  H L Nudelman; R L Kempson
Journal:  Am J Surg       Date:  1966-05       Impact factor: 2.565

4.  Necrosis of the female breast complicating oral anticoagulant treatment.

Authors:  C E Davis; W B Wiley; R J Faulconer
Journal:  Ann Surg       Date:  1972-05       Impact factor: 12.969

5.  [Breast necrosis in anti-vitamin K treatment. Apropos of 2 new cases].

Authors:  A Fourrier; B Combemale; Y Mouton; F Wache; P Taccoen; G Beaucaire
Journal:  Lille Med       Date:  1979 Aug-Sep
  5 in total
  2 in total

1.  A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France.

Authors:  Francesco Salvo; Florent Leborgne; Frantz Thiessard; Nicholas Moore; Bernard Bégaud; Antoine Pariente
Journal:  Drug Saf       Date:  2013-07       Impact factor: 5.606

2.  Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation.

Authors:  Seong Huan Choi; Mina Kim; Hoseob Kim; Dae-Hyeok Kim; Yong-Soo Baek
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.